Standout Papers
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma (2001)
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System (2001)
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance (2019)
- Adoptive T cell therapy using antigen-specific CD8+T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells (2002)
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1 (2008)
Immediate Impact
19 by Nobel laureates 23 from Science/Nature 94 standout
Citing Papers
Renal cell carcinoma
2024 Standout
Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes
2022 StandoutNature
Works of John A. Thompson being referenced
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| John A. Thompson | 9006 | 4222 | 3328 | 110 | 12.1k | |
| Antônio C. Buzaid | 7833 | 2620 | 4126 | 135 | 10.2k | |
| Wyndham H. Wilson | 8771 | 4773 | 3883 | 324 | 17.2k | |
| Svetomir N. Markovic | 6695 | 3898 | 3288 | 340 | 11.7k | |
| Alessandro Testori | 5922 | 2560 | 3523 | 212 | 9.3k | |
| Alan N. Houghton | 7584 | 8789 | 7153 | 207 | 16.7k | |
| Michael A. Postow | 11833 | 5121 | 2801 | 227 | 14.9k | |
| Thomas Eigentler | 6141 | 2381 | 3370 | 263 | 8.9k | |
| Jane L. Messina | 5415 | 2030 | 2804 | 257 | 9.3k | |
| Marc S. Ernstoff | 9864 | 6514 | 5080 | 295 | 15.5k | |
| Crystal L. Mackall | 6851 | 8317 | 3141 | 167 | 15.7k |
All Works
Loading papers...